Aflac Incorporated (NYSE:AFL) is Weaver C. Barksdale & Associates Inc.’s 7th Largest Position

Weaver C. Barksdale & Associates Inc. decreased its holdings in Aflac Incorporated (NYSE:AFL) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,407 shares of the financial services provider’s stock after selling 557 shares during the quarter. Aflac comprises approximately 2.2% of Weaver C. Barksdale & Associates Inc.’s portfolio, making the stock its 7th biggest position. Weaver C. Barksdale & Associates Inc.’s holdings in Aflac were worth $2,318,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Private Trust Co. NA increased its position in Aflac by 1.3% in the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after buying an additional 99 shares in the last quarter. Phillips Wealth Planners LLC grew its position in Aflac by 1.5% in the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares in the last quarter. Raleigh Capital Management Inc. boosted its stake in Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after buying an additional 100 shares during the period. TKG Advisors LLC grew its stake in shares of Aflac by 0.5% during the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after buying an additional 103 shares during the last quarter. Finally, Robertson Stephens Wealth Management LLC increased its stake in Aflac by 1.6% in the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock worth $720,000 after purchasing an additional 107 shares during the period. 67.44% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares in the company, valued at $2,733,048.59. The trade was a 3.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is currently owned by company insiders.

Aflac Trading Down 0.1 %

Shares of AFL stock opened at $109.56 on Wednesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The stock has a 50-day simple moving average of $106.21 and a 200 day simple moving average of $107.62. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50. The stock has a market capitalization of $59.88 billion, a P/E ratio of 11.41, a P/E/G ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on AFL shares. Evercore ISI reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. BMO Capital Markets assumed coverage on Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective for the company. Morgan Stanley upped their price objective on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 7th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.